If you made any changes in Pure, your changes will be visible here soon.

Fingerprint Dive into the research topics where Tae Min Kim is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 48 Similar Profiles
Non-Small Cell Lung Carcinoma Medicine & Life Sciences
temozolomide Medicine & Life Sciences
Glioblastoma Medicine & Life Sciences
Epidermal Growth Factor Receptor Medicine & Life Sciences
Disease-Free Survival Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Survival Medicine & Life Sciences
Protein-Tyrosine Kinases Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 2004 2019

  • 6058 Citations
  • 44 h-Index
  • 231 Article
  • 4 Letter
  • 1 Comment/debate
  • 1 Review article
Non-Small Cell Lung Carcinoma
Drug Therapy
Disease-Free Survival
Cell Death
Confidence Intervals

Pemetrexed in the Treatment of Leptomeningeal Metastasis in Patients With EGFR-mutant Lung Cancer

Choi, M., Keam, B., Ock, C. Y., Kim, M. S., Kim, T. M., Kim, D-W. & Heo, D. S., 1 Jul 2019, In : Clinical Lung Cancer. 20, 4, p. e442-e451

Research output: Contribution to journalArticleResearchpeer-review

Pemetrexed
Lung Neoplasms
Neoplasm Metastasis
Non-Small Cell Lung Carcinoma
Therapeutics

Clinical observation of lymphopenia in patients with newly diagnosed glioblastoma

Kim, W. J., Dho, Y. S., Ock, C. Y., Kim, J. W., Choi, S. H., Lee, S-T., Kim, I. H., Kim, T. M. & Park, C-K., 1 Jun 2019, In : Journal of Neuro-Oncology. 143, 2, p. 321-328 8 p.

Research output: Contribution to journalArticleResearchpeer-review

temozolomide
Lymphopenia
Glioblastoma
Observation
Lymphocytes

NK92-CD16 cells are cytotoxic to non-small cell lung cancer cell lines that have acquired resistance to tyrosine kinase inhibitors

PARK, HA. A. R. A. M., AHN, YONG. O. N. G. O. O. N., Kim, T. M., KIM, SOYEON., KIM, SEULKI., LEE, YU. SOO., Kim, M. S., Keam, B., KIM, DONG. O. N. G. W. A. N. & Heo, D. S., 1 Jun 2019, In : Cytotherapy. 21, 6, p. 603-611 9 p.

Research output: Contribution to journalArticleResearchpeer-review

Non-Small Cell Lung Carcinoma
Protein-Tyrosine Kinases
Cell Line
Immunotherapy
Monoclonal Antibodies
1 Citation (Scopus)

Tracing Oncogene Rearrangements in the Mutational History of Lung Adenocarcinoma

Lee, J. J-K., Park, S., Park, H., Kim, S., Lee, J., Lee, J., Youk, J., Yi, K., An, Y., Park, I. K., Kang, C. H., Chung, D. H., Kim, T. M., Jeon, Y. K., Hong, D., Park, P. J., Ju, Y. S. & Kim, Y. T., May 2019, In : Cell. 177, 7, p. 1842-1857.e21

Research output: Contribution to journalArticleResearchpeer-review

Oncogenes
Oncogene Fusion
Fusion reactions
History
Genes